Characterization of SARS-CoV-2-specific antibodies in COVID-19 patients reveals highly potent neutralizing IgA

Characterization of SARS-CoV-2-specific antibodies in COVID-19 patients reveals highly potent neutralizing IgA

Bibliographic Details
Main Authors:	Weihong Zeng, Huan Ma, Chengchao Ding, Yunru Yang, Yong Sun, Xiaoxue Huang, Weihuang He, Yan Xiang, Yong Gao, Tengchuan Jin
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-01-01
Series:	Signal Transduction and Targeted Therapy
Online Access:	https://doi.org/10.1038/s41392-021-00478-7

Similar Items

IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
by: Isabella Quinti, et al.
Published: (2021-04-01)

Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection
by: Arnaud John Kombe Kombe, et al.
Published: (2021-05-01)

Is SARS-CoV-2 Neutralized More Effectively by IgM and IgA than IgG Having the Same Fab Region?
by: Yalcin Pisil, et al.
Published: (2021-06-01)

The Potential Role of an Aberrant Mucosal Immune Response to SARS-CoV-2 in the Pathogenesis of IgA Nephropathy
by: Zhao Zhang, et al.
Published: (2021-07-01)

Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2
by: Xunyan Ye, et al.
Published: (2021-10-01)

Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
by: Nicholas K. Hurlburt, et al.
Published: (2020-10-01)

IgA Nephropathy After SARS-CoV-2 Vaccination
by: Matthew Abramson, et al.
Published: (2021-09-01)

Performance of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies in South Africa.
by: Maemu P Gededzha, et al.
Published: (2021-01-01)

IgA and IgG antibodies in SARS-CoV-2 vaccinated health workers by a homemade ELISA diagnostic test
by: Luigi Tagliaferro, et al.
Published: (2021-06-01)

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
by: Jiajia Xie, et al.
Published: (2021-08-01)

Potent neutralizing RBD‐specific antibody cocktail against SARS‐CoV‐2 and its mutant
by: Lina Jia, et al.
Published: (2021-09-01)

Comparison of IgA Endomysium Antibody and IgA Tissue Transglutaminase Antibody in Celiac Disease
by: Helen R Gillett, et al.
Published: (2000-01-01)

Antibody screening at reduced pH enables preferential selection of potently neutralizing antibodies targeting SARS‐CoV ‐2
by: Madan, Bharat, et al.
Published: (2022)

Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics
by: Shaojuan Zhao, et al.
Published: (2021-08-01)

Anti-SARS-Cov-2 IgA Response in Tears of COVID-19 Patients
by: Elisabetta Caselli, et al.
Published: (2020-11-01)

Human IgA Monoclonal Antibodies That Neutralize Poliovirus, Produced by Hybridomas and Recombinant Expression
by: Rama Devudu Puligedda, et al.
Published: (2020-02-01)

Structure and function analysis of a potent human neutralizing antibody CA521FALA against SARS-CoV-2
by: Deyong Song, et al.
Published: (2021-04-01)

Analysis of IgM, IgA, and IgG isotype antibodies Directed against SARS-CoV-2 spike glycoprotein and ORF8 in the course of COVID-19
by: Denise Meinberger, et al.
Published: (2021-04-01)

Antigen-Specific IgA Antibodies
by: Hirao, Takao
Published: (2017)

Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses
by: Bailey B. Banach, et al.
Published: (2021-10-01)

Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
by: Arvind Gharbharan, et al.
Published: (2021-05-01)

A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction
by: Monir Ejemel, et al.
Published: (2020-08-01)

IgA-Dominant Infection-Associated Glomerulonephritis Following SARS-CoV-2 Infection
by: Aurora Pérez, et al.
Published: (2021-03-01)

Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients
by: Bernadette Crescenzo-Chaigne, et al.
Published: (2021-12-01)

The real life performance of 7 automated anti-SARS-CoV-2 IgG and IgM/IgA immunoassays
by: Anyszek, T., et al.
Published: (2021)

The real life performance of 7 automated anti-SARS-CoV-2 IgG and IgM/IgA immunoassays
by: Jakub Swadźba, et al.
Published: (2021-05-01)

Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller
by: Bontems, F., et al.
Published: (2022)

Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG
by: Jamiruddin MR, et al.
Published: (2021-06-01)

Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries
by: Yongbing Pan, et al.
Published: (2021-07-01)

Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition
by: Kevin J. Kramer, et al.
Published: (2021-10-01)

SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses
by: Marco Mandolesi, et al.
Published: (2021-04-01)

Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class
by: Micah Rapp, et al.
Published: (2021-04-01)

IgA in IgA nephropathy
by: Layward, Lorna
Published: (1992)

The Effects of Hyperuricemia on the Prognosis of IgA Nephropathy are More Potent in Females
by: Tae Ryom Oh, et al.
Published: (2020-01-01)

Neutralizing antibody titres in SARS-CoV-2 infections
by: Eric H. Y. Lau, et al.
Published: (2021-01-01)

Monoclonal IgA Antibodies for Aflatoxin Immunoassays
by: Özlem Ertekin, et al.
Published: (2016-05-01)

Evaluation of Anti-SARS-CoV-2 IgA in the Conjunctival Secretions of COVID-19 Patients
by: Mahmoud H, et al.
Published: (2021-05-01)

Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity
by: Cyrielle Holuka, et al.
Published: (2021-05-01)

Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers
by: Edurne Rujas, et al.
Published: (2021-06-01)

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
by: Changhai Lei, et al.
Published: (2020-04-01)